# Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/exploration-of-a-potent-pi3-kinase-mtor-inhibitor-as-a-novel-anti-fibrotic-agent/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul F. Mercer,Hannah V. Woodcock,Jessica Eley,Manuela Platé,Michal Sulikowski,Pascal F. Durrenberger,Linda A. Franklin,Carmel B. Nanthakumar,Yim Man,Federica Genovese,Robin J. McAnulty,Shuying Yang,Toby M. Maher,Andrew G. Nicholson,Andy Blanchard,Richard P. Marshall,Pauline T. Lukey,Rachel C. Chambers |
| Citations | 206 |
| DOI | 10.1136/thoraxjnl-2015-207429 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://thorax.bmj.com/content/thoraxjnl/71/8/701.full.pdf |
| OpenAlex ID | https://openalex.org/W2336895811 |
| PMID | 27103349 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Federica Genovese](https://scholariq.org/researchers/federica-genovese/)

## Paper primary topic

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Paper topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.